Lilia-Celine (Lily) Lozada
Stock Analyst at J.P. Morgan
(1.61)
# 3,510
Out of 5,081 analysts
17
Total ratings
60%
Success rate
0.2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lilia-Celine (Lily) Lozada
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XRAY DENTSPLY SIRONA | Reiterated: Hold | $12 | $9.22 | +30.15% | 3 | Sep 17, 2026 | |
| NVST Envista Holdings | Upgraded: Buy | $29 → $32 | $23.66 | +35.25% | 4 | Sep 3, 2026 | |
| ATRC AtriCure | Reiterated: Hold | $36 | $61.08 | -41.06% | 5 | Jul 24, 2026 | |
| TMCI Treace Medical Concepts | Downgraded: Sell | $8 → $5 | $4.42 | +13.12% | 5 | Nov 7, 2025 |
DENTSPLY SIRONA
Sep 17, 2026
Reiterated: Hold
Price Target: $12
Current: $9.22
Upside: +30.15%
Envista Holdings
Sep 3, 2026
Upgraded: Buy
Price Target: $29 → $32
Current: $23.66
Upside: +35.25%
AtriCure
Jul 24, 2026
Reiterated: Hold
Price Target: $36
Current: $61.08
Upside: -41.06%
Treace Medical Concepts
Nov 7, 2025
Downgraded: Sell
Price Target: $8 → $5
Current: $4.42
Upside: +13.12%